| APUs | amphiphilic aliphatic polyurethanes |
| BDI | tetramethylene diisocyanate |
| BDO | 1,4-butanediol |
| BioPUs | biomedical PUs |
| CL | ε-caprolactone |
| CYCLOPHO | cyclophosphamide |
| CS | chitosan |
| CYS | Cystaminedihydrochloride |
| CDI | bis(2-isocyanatoethyl) disulfide |
| DABCO | 1,4-diazabicyclo-[2.2.2]-octane |
| 1,4-DAB | 1,4-diaminobutane |
| 1,2-DAE | 1,2-diaminoethane |
| 1,6-DAH | 1,6-diaminohexane |
| 1,8-DAO | 1,8-diaminooctane |
| DBTDL | dibutyltin dilaurate |
| DBTDO | dibutyltin dioctanate |
| DEG | diethylene glycol |
| DDS/DDSs | drug delivery system(s) |
| DMPA | 2,2-bis(hydroxymethyl)propionic acid |
| DOX | doxorubicin |
| EG | ethylene glycol |
| ECG | epigallocatechin gallate |
| FA | folic acid |
| 5-FU | 5-fluorouracil |
| GG | glycolide |
| GEF | gefitinib |
| GSH | glutathione |
| HDI | hexamethylene diisocyanate |
| HMDI | dicyclohexylmethane 4,4′-diisocyanate |
| HEP | bis-1,4-(hydroxyethyl) piperazine |
| HPEG | hydrazone-ended methoxyl-poly(ethylene glycol) |
| HPCL | hydrazone-embedded poly(ε-caprolactone) diol |
| IC/ICs | diisocyanate/diisocyanates |
| IPDI | isophorone diisocyanate |
| LA | lactide |
| LCST | lower critical solution temperature |
| LDI | L-Lysine diisocyanate ethyl ester |
| L-LYS | L-lysine |
| L-LYS-GQA | L-lysine-derivatized gemini quaternary ammonium salts with two primary amine groups |
| L-LYS-ABA-ABA tripeptide | L-lysine-γ-aminobutyric acid-γ-aminobutyric acid tripeptide |
| mPEG | methoxyl-poly(ethylene glycol) |
| MDEA | N-methyl-diethanolamine |
| MDI | 4,4′-methylenebis(phenyl isocyanate) |
| EG | ethylene glycol |
| METX | Methotrexate |
| bis-MPA | 2,2-bis(hydroxymethyl)-propionic acid |
| NP | nanoparticles |
| O-DTT | trans-4,5-dihydroxy-1,2-dithiane |
| OEDA | dihydroxy(polyethylene adipate) |
| PACL | paclitaxel |
| PBS | phosphate buffered saline |
| PCL | poly(ε-caprolactone) |
| PEG-PU(SS)-PEG | polyurethane with disulfide bonds and PEG fragments |
| PEOtz-OH | poly(2-ethyl-2-oxazoline) |
| PHBHx | poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) |
| PLGA | copolymer of lactide and glycolide |
| PDO | 1,3-propanediol |
| PEG | poly(ethylene glycol) |
| PLA | polylactide |
| PLACL | copolymer of lactide and ε-caprolactone |
| PLA-SS-PLA | PLA with disulfide bonds |
| PNIPAAm-g-chitosan | poly(N-isopropylacrylamide)-grafted-chitosan |
| POEUs | poly(ortho ester urethanes) |
| POx | poly(2-oxazoline)s |
| PPG | poly(propylene glycol) |
| PPG-N3 | azide-grafted PEG |
| PPEG | Propargyl-grafted PEG |
| PPS | poly(1,3-propylene succinate) diols |
| PTMC | poly(trimethylene carbonate) |
| PTMC-SS-PTMC | PTMC with disulfide bonds |
| PTMG | poly(tetramethylene ether) glycol |
| PUs | polyurethanes |
| PU-DDSs | polyurethane drug delivery systems |
| PU-Prodrugs | polyurethane prodrugs |
| PU-SS-COOH | polyurethane obtained from PEG-1000, PCL-2000, HDI, CYS and DMPA |
| PU-SS-COOH-NH2 | product of condensation reaction between the PU-SS-COOH and 1,6-diaminohexane |
| ROP | ring-opening polymerization |
| SnOct2 | tin(II) 2-ethylhexanoate |
| SPION | superparamagnetic iron oxide nanoparticles |
| TDI | toluene 2,4-diisocyanate |
| TMC | trimethylene carbonate |
| TMZ | temozolomide |
| WPU | waterborne polyurethane dispersions |